198 related articles for article (PubMed ID: 26089695)
1. IncobotulinumtoxinA in aesthetics: Russian multidisciplinary expert consensus recommendations.
Yutskovskaya Y; Gubanova E; Khrustaleva I; Atamanov V; Saybel A; Parsagashvili E; Dmitrieva I; Sanchez E; Lapatina N; Korolkova T; Saromytskaya A; Goltsova E; Satardinova E
Clin Cosmet Investig Dermatol; 2015; 8():297-306. PubMed ID: 26089695
[TBL] [Abstract][Full Text] [Related]
2. International Consensus Recommendations on the Aesthetic Usage of Ready-to-Use AbobotulinumtoxinA (Alluzience).
Ascher B; Rzany BJ; Kestemont P; Redaelli A; Hendrickx B; Iozzo I; Martschin C; Milotich A; Molina B; Cartier H; Picaut P; Prygova I
Aesthet Surg J; 2024 Jan; 44(2):192-202. PubMed ID: 37490767
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Lateral Periorbital Lines with Different Dilutions of IncobotulinumtoxinA.
Muti GF; Basso M
J Clin Aesthet Dermatol; 2017 Sep; 10(9):27-29. PubMed ID: 29344324
[No Abstract] [Full Text] [Related]
4. Assessment of the Efficacy and Durability of IncobotulinumtoxinA in the Treatment of the Upper Face in Adult Women.
de Almeida AT; de Sanctis Pecora C; Marques ER; Contin L; de Almeida CT; da Cunha AL
Dermatol Ther (Heidelb); 2024 Jul; ():. PubMed ID: 38954382
[TBL] [Abstract][Full Text] [Related]
5. Clinical equivalence of conventional OnabotulinumtoxinA (900 KDa) and IncobotulinumtoxinA (neurotoxin free from complexing proteins - 150 KDa): 2012 multidisciplinary French consensus in aesthetics.
Poulain B; Trevidic P; Clave M; Aharoni C; Baspeyras M; Bui P; Cartier H; Charavel MH; Coulon P; Dahan S; Dallara JM; Delonca D; Dumas L; Essayagh E; Galatoire O; Georgieu N; Grangier Y; Humbert P; Le Pillouer-Prost A; Mojallal A
J Drugs Dermatol; 2013 Dec; 12(12):1434-46. PubMed ID: 24301246
[TBL] [Abstract][Full Text] [Related]
6. Differential characteristics of incobotulinumtoxinA and its use in the management of glabellar frown lines.
Prager W
Clin Pharmacol; 2013; 5():39-52. PubMed ID: 23516136
[TBL] [Abstract][Full Text] [Related]
7. Consensus recommendations on the use of botulinum toxin type a in facial aesthetics.
Carruthers J; Fagien S; Matarasso SL;
Plast Reconstr Surg; 2004 Nov; 114(6 Suppl):1S-22S. PubMed ID: 15507786
[TBL] [Abstract][Full Text] [Related]
8. SAMCEP Society consensus on the treatment of upper facial lines with botulinum neurotoxin type A: A tailored approach.
Braccini F; Catoni I; Belfkira F; Lagier J; Roze E; Paris J; Huth J; Bronsard V; Cartier H; David M; Galatoire O; Obadia D; Sabatier H; Sarfati E; Kestemont P; Winter C; Redaelli A
J Cosmet Dermatol; 2023 Oct; 22(10):2692-2704. PubMed ID: 37408173
[TBL] [Abstract][Full Text] [Related]
9. Safety, Tolerability, and Efficacy of Repeat-Dose Injections of IncobotulinumtoxinA in the Treatment of Upper Facial Lines: Results from a Prospective, Open-Label, Phase III Study.
Fischer T; Sattler G; Prager W; Rzany B; Pavicic T; Gauglitz G; Weissenberger P; Riaz S
J Drugs Dermatol; 2020 May; 19(5):461-469. PubMed ID: 32484631
[TBL] [Abstract][Full Text] [Related]
10. IncobotulinumtoxinA use in aesthetic indications in daily practice: a European multicenter, noninterventional, retrospective study.
Pavicic T; Prager W; Klöppel M; Ravichandran S; Galatoire O
Clin Cosmet Investig Dermatol; 2015; 8():135-42. PubMed ID: 25834463
[TBL] [Abstract][Full Text] [Related]
11. Italian consensus report on the aesthetic use of onabotulinum toxin A.
Bertossi D; Cavallini M; Cirillo P; Piero Fundarò S; Quartucci S; Sciuto C; Tonini D; Trocchi G; Signorini M
J Cosmet Dermatol; 2018 Oct; 17(5):719-730. PubMed ID: 30091253
[TBL] [Abstract][Full Text] [Related]
12. IncobotulinumtoxinA for Aesthetic Indications: A Systematic Review of Prospective Comparative Trials.
Prager W; Nogueira Teixeira D; Leventhal PS
Dermatol Surg; 2017 Jul; 43(7):959-966. PubMed ID: 28375973
[TBL] [Abstract][Full Text] [Related]
13. IncobotulinumtoxinA for the Treatment of Glabella and Forehead Dynamic Lines: A Real-Life Longitudinal Case Series.
da Cunha ALG; Vasconcelos R; Di Sessa D; Sampaio G; Ramalhoto P; Zampieri BF; Deus BS; Vasconcelos S; Bellote T; Carvalho J; Petrone G; Figueredo V; Limongi Moreira G
Clin Cosmet Investig Dermatol; 2023; 16():697-704. PubMed ID: 36987400
[TBL] [Abstract][Full Text] [Related]
14. A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins.
Jimenez-Shahed J
Neuropsychiatr Dis Treat; 2012; 8():13-25. PubMed ID: 22275842
[TBL] [Abstract][Full Text] [Related]
15. Duration and onset of effect of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-naïve subjects.
Mitsikostas DD; Dekundy A; Hanschmann A; Althaus M; Scheschonka A; Pagan F; Jankovic J
Curr Med Res Opin; 2021 Oct; 37(10):1761-1768. PubMed ID: 34384301
[TBL] [Abstract][Full Text] [Related]
16. Aesthetic use of BoNT: Options and outcomes.
Gendler E; Nagler A
Toxicon; 2015 Dec; 107(Pt A):120-8. PubMed ID: 26368007
[TBL] [Abstract][Full Text] [Related]
17. IncobotulinumtoxinA: A Highly Purified and Precisely Manufactured Botulinum Neurotoxin Type A.
Kerscher M; Wanitphakdeedecha R; Trindade de Almeida A; Maas C; Frevert J
J Drugs Dermatol; 2019 Jan; 18(1):52-57. PubMed ID: 30681794
[TBL] [Abstract][Full Text] [Related]
18. Cosmetic Treatment Using Botulinum Toxin in the Oral and Maxillofacial Area: A Narrative Review of Esthetic Techniques.
Hong SO
Toxins (Basel); 2023 Jan; 15(2):. PubMed ID: 36828397
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Upper Facial Lines: Results From a Randomized, Double-Blind, Placebo-Controlled, Phase III Study.
Kerscher M; Rzany B; Prager W; Turnbull C; Trevidic P; Inglefield C
Dermatol Surg; 2015 Oct; 41(10):1149-57. PubMed ID: 26359996
[TBL] [Abstract][Full Text] [Related]
20. OnabotulinumtoxinA from lines to facial reshaping: A new Italian consensus report.
Signorini M; Piero Fundarò S; Bertossi D; Cavallini M; Cirillo P; Natuzzi G; Quartucci S; Sciuto C; Patalano M; Trocchi G
J Cosmet Dermatol; 2022 Feb; 21(2):550-563. PubMed ID: 35060310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
